← Back to Search

Device

CPAP Therapy for Sleep Apnea

N/A
Recruiting
Led By Ali Azarbarzin, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 21-80 years
Be older than 18 years old
Must not have
Use of medications that might depress respiration (including opioids, barbiturates, benzodiazepines, and Z drugs, including zolpidem, zopiclone, eszopiclone, and zaleplon)
Sleep disordered breathing or respiratory disorders other than obstructive sleep apnea: central sleep apnea (>50% of respiratory events scored as central), chronic hypoventilation/hypoxemia (awake SaO2 < 92% by oximetry) due to chronic obstructive pulmonary disease or other respiratory conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying whether or not CPAP can help people with obstructive sleep apnea (OSA) by better characterizing OSA-related physiological consequences during sleep.

Who is the study for?
Adults aged 21-80 with moderate to severe obstructive sleep apnea (OSA) and an apnea-hypopnea index over 15 events/hr are eligible. They must not be currently treated for OSA, have uncontrolled medical issues, heart failure, renal insufficiency, neurological conditions affecting respiration, or use respiratory-depressing meds. Pregnant women and those with other sleep disorders or active non-prescription opioid use are excluded.
What is being tested?
The trial is testing the effectiveness of Continuous Positive Airway Pressure (CPAP) in treating OSA by using new metrics to assess hypoxemia ('hypoxic burden'), autonomic response ('heart rate burden'), and sleep fragmentation ('arousal burden') rather than just the apnea-hypopnea index.
What are the potential side effects?
While CPAP is generally safe, potential side effects include discomfort or irritation from the mask interface, dry nose or throat, nasal congestion, headaches, bloating and difficulty tolerating forced air.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking medications that can slow my breathing.
Select...
I have a sleep or breathing disorder other than obstructive sleep apnea.
Select...
I have a history of heart failure, kidney issues, or neurological conditions affecting my breathing.
Select...
I cannot or do not want to use CPAP.
Select...
I have a diagnosed sleep disorder like narcolepsy or frequent limb movements.
Select...
I often can't sleep for more than 6 hours a night.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline 24-hour mean systolic blood pressure at 12 weeks
Change from baseline Epworth Sleepiness Scale (ESS) at 12 weeks
Change from baseline flow-mediated vasodilation at 12 weeks
Secondary study objectives
Change from baseline 24-hour mean blood pressure at 12 weeks
Change from baseline 24-hour mean diastolic blood pressure at 12 weeks
Change from baseline Albumin without Creatinine at 12 weeks
+19 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Positive Airway Pressure DeviceExperimental Treatment1 Intervention
All participants will receive PAP therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PAP
2016
N/A
~90

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,841,466 Total Patients Enrolled
12 Trials studying Sleep Apnea
6,702 Patients Enrolled for Sleep Apnea
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,936 Previous Clinical Trials
47,792,495 Total Patients Enrolled
15 Trials studying Sleep Apnea
5,400 Patients Enrolled for Sleep Apnea
Ali Azarbarzin, PhDPrincipal Investigator - Brigham and Women's Hospital
Brigham and Women's Hospital

Media Library

PAP (Device) Clinical Trial Eligibility Overview. Trial Name: NCT04575740 — N/A
Sleep Apnea Research Study Groups: Positive Airway Pressure Device
Sleep Apnea Clinical Trial 2023: PAP Highlights & Side Effects. Trial Name: NCT04575740 — N/A
PAP (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04575740 — N/A
~3 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top